GSK 2023 ApS: Financial statements 2013
CVR: 43456415
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
GSK 2023 ApS (CVR 43456415) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 2,876,263 and a net result of DKK 3,833,953 compared with DKK 3,888,209 the year before. That is a decrease of 8.6% compared with the year before. Equity in the 2013 report amounted to DKK 44,783,804. The solvency ratio was 76.4%.
- Gross Profit
- DKK 2,876,263
- Profit/Loss
- DKK 3,833,953
- Equity
- DKK 44,783,804
- Total Assets
- DKK 58,643,468
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 2.9 mio. | 3.8 mio. | 44.8 mio. | - |
| 2012 | - | 3.1 mio. | 3.9 mio. | 40.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
GSK 2023 ApS has published its annual report for 2012. Gross profit came to DKK 3,146,974, and the net result was DKK 3,888,209.
About GSK 2023 ApS
GSK 2023 ApS is a Danish company of the type Anpartsselskab based in Sæby, founded in 1972. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named B6 HOLDING A/S and B 6 AF 1972 A/S. The management consists of Brian Stenbro. The board consists of Kurt Valdemar Stenbro (chair), Brian Stenbro and Malene Stenbro. The company is owned by M.A.S.T. Holding ApS, BriSt Holding 2023 ApS and KVS Holding, Sæby ApS. The company has 2 employees (2023). In 2025, the company reported a gross profit of DKK -30,332 and a net result of DKK -5,937 compared with DKK 372,677 the year before. Equity in the 2025 report amounted to DKK 4,181,703.